Ligand Pharma (Nasdaq: LGND) announces the signing of a commercial license agreement with Avion Pharmaceuticals, LLC for the development and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE